NASDAQ: SNDX Syndax Pharmaceuticals Inc 8-K

Syndax Pharmaceuticals reports Q4 and full-year fiscal 2026 financial results

Filed April 30, 2026 · Period ending April 30, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SNDX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 5, 2026 4:56 PM